Central Trust Company’s Arrowhead Research ARWR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-59
Closed -$933 1417
2025
Q2
$933 Hold
59
﹤0.01% 1374
2025
Q1
$752 Hold
59
﹤0.01% 1393
2024
Q4
$1.11K Hold
59
﹤0.01% 1375
2024
Q3
$1.14K Hold
59
﹤0.01% 1303
2024
Q2
$1.53K Hold
59
﹤0.01% 1306
2024
Q1
$1.69K Hold
59
﹤0.01% 1288
2023
Q4
$1.81K Hold
59
﹤0.01% 1292
2023
Q3
$1.59K Buy
+59
New +$1.81K ﹤0.01% 1283
2022
Q3
Sell
-6
Closed 1299
2022
Q2
$0 Sell
6
-450
-99% -$16.9K ﹤0.01% 1360
2022
Q1
$21K Sell
456
-169
-27% -$8.37K ﹤0.01% 943
2021
Q4
$42K Sell
625
-50
-7% -$3.44K ﹤0.01% 815
2021
Q3
$42K Hold
675
﹤0.01% 790
2021
Q2
$55K Buy
675
+175
+35% +$13K ﹤0.01% 716
2021
Q1
$33K Hold
500
﹤0.01% 755
2020
Q4
$38K Buy
+500
New +$32K ﹤0.01% 725

Other funds holding ARWR

Central Trust Company's ARWR Position: Q3 2025 in Review

Central Trust Company sold out of Arrowhead Research (ARWR) in Q3 2025, closing a stake of 59 shares — an estimated $933 sold.

Central Trust Company first reported a position in ARWR in Q4 2020 and held it in 15 quarters. The position peaked at $55K in Q2 2021. 304 funds tracked by Wall St. Rank hold ARWR as of Q3 2025.

  • Central Trust Company reported no remaining Arrowhead Research position as of Q3 2025 after selling out during the quarter.
  • Central Trust Company sold 59 Arrowhead Research shares in Q3 2025, an estimated $933.
  • Central Trust Company first reported a position in Arrowhead Research in Q4 2020 and held it in 15 quarters.
  • Central Trust Company's Arrowhead Research position peaked at $55K in Q2 2021.
  • 304 funds tracked by Wall St. Rank held Arrowhead Research as of Q3 2025.

Based on Central Trust Company's 13F filing for Q3 2025, filed 6 Nov 2025.